glucose, (beta-d)-isomer has been researched along with Atypical Hemolytic-Uremic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baas, LM; Bouwmeester, RN; Dorresteijn, EM; Michels, MAHM; Stevens, KH; van de Kar, NCAJ; van den Heuvel, LP; van der Velden, TJAM; van Dillen, N; van Zuilen, AD; Wetzels, JFM | 1 |
| Guo, R; Habel, M; Hermann, M; Kentouche, K; Kirschfink, M; Riedemann, NC; Schneider, C; Wehling, C; Ziereisen, J | 1 |
| Mollnes, TE; van de Kar, NC; van den Heuvel, LP; van der Velden, TJ; Volokhina, EB; Westra, D | 1 |
3 other study(ies) available for glucose, (beta-d)-isomer and Atypical Hemolytic-Uremic Syndrome
| Article | Year |
|---|---|
Modeling complement activation on human glomerular microvascular endothelial cells.
Topics: Atypical Hemolytic Uremic Syndrome; Complement Activation; Complement Membrane Attack Complex; Complement System Proteins; Endothelial Cells; Humans; Zymosan | 2023 |
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition.
Topics: Antibodies, Monoclonal, Humanized; Atypical Hemolytic Uremic Syndrome; Complement C3-C5 Convertases; Complement C5a; Glomerulonephritis; Humans; Thrombin; Trypsin; Zymosan | 2017 |
Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
Topics: Acute Disease; Adolescent; Adult; Atypical Hemolytic Uremic Syndrome; Case-Control Studies; Child; Child, Preschool; Complement Activation; Complement C3b; Complement Factor B; Complement Factor H; Complement Membrane Attack Complex; Complement Pathway, Alternative; Female; Humans; Infant; Male; Middle Aged; Platelet-Rich Plasma; Protein Isoforms; Remission Induction; Renal Dialysis; Zymosan | 2015 |